Document Classification

Section Type: RESULTS

Text: After 12 weeks of rimonabant there was a significant reduction (mean + / - SEM) in weight (104. 6 + / - 4. 6 vs. 98. 4 + / - 4. 7 kg, P < 0. 01), waist circumference (116. 0 + / - 3. 3 vs. 109. 2 + / - 3. 7 cm, P < 0. 01), hip circumference (128. 5 + / - 4. 0 vs. 124. 1 + / - 4. 2 cm, P < 0. 03), waist-hip ratio (0. 90 + / - 0. 02 vs. 0. 88 + / - 0. 01, P < 0. 01) free androgen index (FAI) (26. 6 + / - 6. 1 vs. 16. 6 + / - 4. 1, P < 0. 01), testosterone [4. 6 + / - 0. 4 vs. 3. 1 + / - 0. 3 nmol/l (132. 7 + / - 11. 5 vs. 89. 4 + / - 8. 65 ng/dl), P < 0. 01] and insulin resistance as measured by the homeostasis model assessment (HOMA) method (4. 4 + / - 0. 5 vs. 3. 4 + / - 0. 4, P = 0. 05).